These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
3. Topiramate monotherapy for juvenile myoclonic epilepsy. Liu J; Wang LN; Wang YP Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884 [TBL] [Abstract][Full Text] [Related]
4. Topiramate monotherapy for juvenile myoclonic epilepsy. Liu J; Wang LN; Wang YP Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010008. PubMed ID: 28434203 [TBL] [Abstract][Full Text] [Related]
5. Use of topiramate in childhood generalized seizure disorders. Wheless JW J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056 [TBL] [Abstract][Full Text] [Related]
6. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366 [TBL] [Abstract][Full Text] [Related]
7. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Montouris G; Abou-Khalil B Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728 [TBL] [Abstract][Full Text] [Related]
8. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Levisohn PM; Holland KD Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520 [TBL] [Abstract][Full Text] [Related]
9. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623 [TBL] [Abstract][Full Text] [Related]
14. Topiramate for the treatment of juvenile myoclonic epilepsy. Sousa Pda S; Araújo Filho GM; Garzon E; Sakamoto AC; Yacubian EM Arq Neuropsiquiatr; 2005 Sep; 63(3B):733-7. PubMed ID: 16258645 [TBL] [Abstract][Full Text] [Related]
15. Preliminary open-label experience with topiramate in primary generalized seizures. Biton V Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959 [TBL] [Abstract][Full Text] [Related]
16. A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy. Park KM; Kim SH; Nho SK; Shin KJ; Park J; Ha SY; Kim SE J Clin Neurosci; 2013 Aug; 20(8):1079-82. PubMed ID: 23673144 [TBL] [Abstract][Full Text] [Related]
17. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate. de Araujo Filho GM; Pascalicchio TF; Lin K; Sousa PS; Yacubian EM Epilepsy Behav; 2006 May; 8(3):606-9. PubMed ID: 16504593 [TBL] [Abstract][Full Text] [Related]
19. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE; Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489 [TBL] [Abstract][Full Text] [Related]